Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

维生素D缺乏被认为是MS的危险因素之一，但关于维生素D补充的益处仍存在争议。2025年3月10日，发表于JAMA的一项研究发现：每2周口服100,000 IU胆钙化醇显著减少了CIS和早期复发缓解型MS患者的疾病活动性，为维生素D在MS治疗中的潜在作用提供了新的证据， ...

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...

Researchers from institutions across France have uncovered solid clinical evidence that supplements of vitamin D could be an ...

Several randomized controlled trials (RCTs) have shown that when DMTs are initiated in patients at presentation with a clinically isolated syndrome, the probability of evolution to definite MS ...

A significant benefit was observed with Tysabri over Rebif in delaying SPMS disability progression when therapeutic lag was ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams.